{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:59:22Z","timestamp":1774933162653,"version":"3.50.1"},"reference-count":37,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.2967\/jnumed.119.239624","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T02:45:21Z","timestamp":1580525121000},"page":"1307-1313","source":"Crossref","is-referenced-by-count":18,"title":["<sup>18<\/sup>F-FDG PET\/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders"],"prefix":"10.2967","volume":"61","author":[{"given":"Filipe M.","family":"Montes de Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andor W.J.M.","family":"Glaudemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim J.","family":"Tissing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi A.J.O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjan","family":"Diepstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Kwee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"2021051712151490000_61.9.1307.1","unstructured":"Swerdlow SH Campo E Harris NL . Post-transplant lymphoproliferative disorders (PTLD). In: Swerdlow S, Campo E, Harris N, et al., eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Vol 2. 4th ed. Lyon, France: International Agency for Research on Cancer;2017:453\u2013462."},{"key":"2021051712151490000_61.9.1307.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.015"},{"key":"2021051712151490000_61.9.1307.3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx","year":"2018","journal-title":"N Engl J Med."},{"key":"2021051712151490000_61.9.1307.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08161.x"},{"key":"2021051712151490000_61.9.1307.5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOP.0000000000000445","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"29","author":"Llaurador","year":"2017","journal-title":"Curr Opin Pediatr."},{"key":"2021051712151490000_61.9.1307.6","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00325.x"},{"key":"2021051712151490000_61.9.1307.7","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1111\/ajt.15358","article-title":"Posttransplant lymphoproliferative disorder in pediatric patients: survival rates according to primary sites of occurrence and a proposed clinical categorization","volume":"19","author":"L\u2019Huillier","year":"2019","journal-title":"Am J Transplant."},{"key":"2021051712151490000_61.9.1307.8","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.2001.00059.x"},{"key":"2021051712151490000_61.9.1307.9","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-013-0162-5"},{"key":"2021051712151490000_61.9.1307.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/TRRM.S84744","article-title":"Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach","volume":"9","author":"Ligeti","year":"2017","journal-title":"Transpl Res Risk Manag."},{"key":"2021051712151490000_61.9.1307.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit391"},{"key":"2021051712151490000_61.9.1307.12","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-010-9329-8"},{"key":"2021051712151490000_61.9.1307.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2008.00938.x"},{"key":"2021051712151490000_61.9.1307.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2007.01.007"},{"key":"2021051712151490000_61.9.1307.15","doi-asserted-by":"crossref","first-page":"e26685","DOI":"10.1002\/pbc.26685","article-title":"Preliminary experience on the use of PET\/CT in the management of pediatric post-transplant lymphoproliferative disorder","volume":"64","author":"Guerra-Garc\u00eda","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"2021051712151490000_61.9.1307.16","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.813501"},{"key":"2021051712151490000_61.9.1307.17","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0000000000000050"},{"key":"2021051712151490000_61.9.1307.18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/petr.12611","article-title":"The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis","volume":"19","author":"Vali","year":"2015","journal-title":"Pediatr Transplant."},{"key":"2021051712151490000_61.9.1307.19","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200512000-00010"},{"key":"2021051712151490000_61.9.1307.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0826-x"},{"key":"2021051712151490000_61.9.1307.21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.0229"},{"key":"2021051712151490000_61.9.1307.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.5866"},{"key":"2021051712151490000_61.9.1307.23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2021051712151490000_61.9.1307.24","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2021051712151490000_61.9.1307.25","first-page":"136","article-title":"The role of 18F-FDG PET\/CT in the evaluation of pediatric transplant patients","volume":"18","author":"Yang","year":"2015","journal-title":"Hell J Nucl Med."},{"key":"2021051712151490000_61.9.1307.26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.074500"},{"key":"2021051712151490000_61.9.1307.27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00259-019-04481-7","article-title":"Diagnostic performance of FDG-PET\/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield","volume":"47","author":"Montes de Jesus","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712151490000_61.9.1307.28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00259-019-04518-x","article-title":"18F-FDG PET\/CT in patients with post-transplant lymphoproliferative disorders: so far so good","volume":"47","author":"Treglia","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712151490000_61.9.1307.29","doi-asserted-by":"publisher","DOI":"10.1148\/rg.295085247"},{"key":"2021051712151490000_61.9.1307.30","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00247-017-3835-8","article-title":"FDG uptake in cervical lymph nodes in children without head and neck cancer","volume":"47","author":"Vali","year":"2017","journal-title":"Pediatr Radiol."},{"key":"2021051712151490000_61.9.1307.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02167.x"},{"key":"2021051712151490000_61.9.1307.32","doi-asserted-by":"publisher","DOI":"10.1148\/rg.271065080"},{"key":"2021051712151490000_61.9.1307.33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1590\/0037-8682-0036-2014","article-title":"Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients","volume":"47","author":"Marques","year":"2014","journal-title":"Rev Soc Bras Med Trop."},{"key":"2021051712151490000_61.9.1307.34","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3282f1d706"},{"key":"2021051712151490000_61.9.1307.35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2018.09.007","article-title":"Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: a systematic review and meta-analysis","volume":"132","author":"Montes","year":"2018","journal-title":"Crit Rev Oncol Hematol."},{"key":"2021051712151490000_61.9.1307.36","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.mayocp.2018.04.025","article-title":"Immunosuppression, race, and donor-related risk factors affect de novo cancer incidence across solid organ transplant recipients","volume":"93","author":"Bhat","year":"2018","journal-title":"Mayo Clin Proc."},{"key":"2021051712151490000_61.9.1307.37","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.ejrad.2016.08.011","article-title":"Proportion of false-positive lesions at interim and end-of-treatment FDG-PET in lymphoma as determined by histology: systematic review and meta-analysis","volume":"85","author":"Adams","year":"2016","journal-title":"Eur J Radiol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.239624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:50:26Z","timestamp":1621284626000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.239624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,1]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.2967\/jnumed.119.239624"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.239624","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}